DCGI approves study on mixing Covaxin, Covishield- Details here

The Drugs Controller General of India (DCGI) has given its approval for conducting a study on mixing of Covaxin and Covishield Covid-19 vaccines in India.

"Drugs Controller General of India gives nod for conducting a study on mixing Covaxin & Covishield," news agency ANI tweeted on Wednesday.

See Zee Business Live TV Streaming Below:

Recently, the Indian Council of Medical Research (ICMR) had revealed in its study that the combination of Covaxin and Covishield vaccines conducted on 18 people, has elicited better safety and immunogenicity results.

Drugs Controller General of India gives nod for conducting a study on mixing Covaxin & Covishield. pic.twitter.com/twudwqBAXu

— ANI (@ANI) August 11, 2021

According to a report by ANI, in the study, ICMR compared the safety and immunogenicity profile with those individuals who received either Covaxin or Covishield and it showed better results.

The study conducted on individuals in the northern state of Uttar Pradesh in India received Covishield as the first dose followed by inadvertent administration of Covaxin as the second dose at an interval of six weeks.

The nationwide vaccination program had entered into 4th month when the event of mixed dosing raised considerable anxiety in the public domain with the potential to contributing to vaccine hesitancy. ICMR conducted the investigation against this backdrop.